Lethal Larsen-like syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

Regulatory Watchboard

10 events
Mar 2026

KETAMINE HYDROCHLORIDE: New indication approved

FDAcompleted
Mar 2026KETALAR: New indication approved
FDAcompleted
Mar 2026

KETALAR: New indication approved

FDAcompleted
Oct 2025KETALAR: New indication approved
FDAcompleted
Jan 2023

KETAMINE HYDROCHLORIDE: FDA approved

FDAcompleted
Aug 2022KETALAR: New indication approved
FDAcompleted
Jun 2022KETALAR: New indication approved
FDAcompleted
Aug 2020KETALAR: New indication approved
FDAcompleted
Aug 2018KETALAR: New indication approved
FDAcompleted
Apr 2017KETALAR: New indication approved
FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Lethal Larsen-like syndrome.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Lethal Larsen-like syndrome.
Search all trials →
Search clinical trials for Lethal Larsen-like syndrome

Recent News & Research

No recent news articles indexed yet for Lethal Larsen-like syndrome.
Search PubMed for Lethal Larsen-like syndrome

Browse all Lethal Larsen-like syndrome news →

Specialist Network

No specialists currently listed for Lethal Larsen-like syndrome.

View all Lethal Larsen-like syndrome specialists →

Quick Actions